mefloquine is used to both prevent and treat certain forms of malaria mefloquine is useful for the prevention of malaria in all areas except for those where parasites may have resistance to multiple medications , and is one of several anti-malarial medications recommended by the united states centers for disease control and prevention for this purpose it is also recommended by the infectious disease society of america for malaria prophylaxis as a first or second-line agent , depending on resistance patterns in the malaria found in the geographic region visited if a person becomes ill with malaria despite prophylaxis with mefloquine , the use of halofantrine and quinine for treatment may be ineffective mefloquine is used as a treatment for chloroquine-sensitive or resistant plasmodium falciparum malaria , and is deemed a reasonable alternative for uncomplicated chloroquine-resistant plasmodium vivax malaria common side effects include vomiting , diarrhea , headaches , and a rash severe side effects requiring hospitalization are rare , but include mental health problems such as depression , hallucinations , anxiety and neurological side effects such as ataxia , seizures , and tinnitus mefloquine is therefore not recommended in people with a history of psychiatric disorders or epilepsy food and drug administration ( fda ) added a boxed warning to the prescription label of mefloquine regarding the potential for neuropsychiatric side effects that may persist even after discontinuing administration of the medication in 2013 the fda stated '' neurologic side effects can occur at any time during drug use , and can last for months to years after the drug is stopped or can be permanent central nervous system events requiring hospitalization occur in about one in 10,000 people taking mefloquine for malaria prevention , with milder events ( e.g combining mefloquine with other drugs that cause similar effects , such as quinine or quinidine , can increase these effects available data suggests that mefloquine is safe and effective for use by pregnant women during all trimesters of pregnancy , and it is widely used for this indication in pregnant women , mefloquine appears to pose minimal risk to the fetus , and is not associated with increased risk of birth defects or miscarriages by 1994 , medical professionals were noting '' severe psychiatric side effects observed during prophylaxis and treatment with mefloquine '' , and recommending that '' the absence of contraindications and minor side effects during an initial course of mefloquine should be confirmed before another course is prescribed canadian soldiers who took mefloquine when deployed overseas have claimed they have been left with ongoing mental health problems 